Yüklüyor......
Intermittent, low-dose, antiandrogen monotherapy as an alternative therapeutic option for patients with positive surgical margins after radical prostatectomy
The aim of the present study was to determine whether oncologic outcomes and adverse events associated with active on/off intermittent antiandrogen monotherapy (daily bicalutamide, 50 mg per day) are comparable with those of standard external beam radiation therapy (EBRT) or combined androgen blocka...
Kaydedildi:
| Yayımlandı: | Asian J Androl |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Medknow Publications & Media Pvt Ltd
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5952482/ https://ncbi.nlm.nih.gov/pubmed/29271399 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/aja.aja_56_17 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|